The demethylating agent 5-Aza-2'-deoxycytidine (5-AZA-CdR) inhibits the development of preimplantation mouse embryos

Progress in Biochemistry and Biophysics

Volumn 36, Issue 2, 2009, Pages 228-237

  Yu, Jian Ning ^a,b   Li, Shao Hua ^b   Wang, Dan Qiu ^b   Wang, Meng ^b   Lin, Fei ^b   Liu, Hong Lin ^b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

5 AZA CdR; Apoptosis; Development; DNA methylation; Transcriptional activity

Indexed keywords

MAMMALIA;

EID: 67649545099     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2008.00394     Document Type: Article

References (60)

1. Rogers J M, Francis B M, Sulik K K, et al. Cell death and cell cycle perturbation in the developmental toxicity of the demethylating agent, 5-AZA-2'- deoxycytidine. Teratology, 1994, 50(5): 332-339
2. Okano M, Bell D W, Haber D A, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 1999, 99(3): 247-257
3. Walsh C.P. Bestor T.H. Cytosine methylation and mammalian development Genes and Development 1999 13 1 26-34 3 Walsh C P, Bestor T H. Cytosine methylation and mammalian development. Genes Dev, 1999, 13(1): 26-34 (Pubitemid 29045113)
4. Jackson-Grusby L, Beard C, Possemato R, et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet, 2001, 27(1): 31-39
5. Reik W. Dean W. DNA methylation and mammalian epigenetics Electrophoresis 2001 22 14 2838-2843 DOI 10.1002/1522-2683(200108)22:14<2838::AID- ELPS2838>3.0.CO;2-M 5 Reik W, Dean W. DNA methylation and mammalian epigenetics. Electrophoresis, 2001, 22(14): 2838-2843 (Pubitemid 32851180)
6. Jost J P, Oakeley E J, Zhu B, et al. 5-Methylcytosine DNA glyeosylase participates in the genome-wide loss of DNA methylation occurring during mouse myoblast differentiation. Nucleic Acids Res, 2001, 29(21): 4452-4461
7. Reik W. Dean W. Walter J. Epigenetic reprogramming in mammalian development Science 2001 293 5532 1089-1093 DOI 10.1126/science.1063443 7 Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science, 2001, 293 (5532): 1089-1093 (Pubitemid 32758081)
8. Heard E. Clerc P. Avner P. X-chromosome inactivation in mammals Annual Review of Genetics 1997 31 571-610 DOI 10.1146/annurev.genet.31.1.571 8 Heard E, Clerc P, Avner P. X-chromosome inactivation in mammals. Annu Rev Genet, 1997, 31: 571-610 (Pubitemid 28023720)
9. Baylin S.B. Tying it all together: Epigenetics, genetics, cell cycle, and cancer Science 1997 277 5334 1948-1949 DOI 10.1126/science.277.5334.1948 9 Baylin S B. Tying it all together: epigenetics, genetics, cell cycle, and cancer. Science, 1997, 277(5334): 1948-1949 (Pubitemid 27449125)
10. Cooney C.A. Are somatic cells inherently deficient in methylation metabolism? A proposed mechanism for DNA methylation loss, senescence and aging Growth, Development and Aging 1993 57 4 261-273 10 Cooney C A. Are somatic cells inherently deficient in methylation metabolism? A proposed mechanism for DNA methylation loss, senescence and aging. Growth Dev Aging, 1993, 57(4): 261-273 (Pubitemid 23363343)
11. Issa J.-P. CpG-island methylation in aging and cancer Current Topics in Microbiology and Immunology 2000 249 101-118 11 Issa J P. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol, 2000, 249:101-118 (Pubitemid 30133496)
12. Mayer W, Niveleau A, Walter J, et al. Demethylation of the zygotic paternal genome. Nature, 2000, 403(6769): 501-502
13. Oswald J, Engemann S, Lane N, et al. Active demethylation of the paternal genome in the mouse zygote. Curr Biol, 2000, 10(8): 475-478
14. Santos F, Hendrich B, Reik W, et al. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol, 2002, 241 (1): 172-182
15. Young L.E. Beaujean N. DNA methylation in the preimplantation embryo: The differing stories of the mouse and sheep Animal Reproduction Science 2004 82 83 61-78 DOI 10.1016/j.anireprosci.2004.05.020, PII S0378432004001071 15 Young L E, Beaujean N. DNA methylation in the preimplantation embryo: the differing stories of the mouse and sheep. Anim Reprod Sci, 2004, 82-83: 61-78 (Pubitemid 39027050)
16. Howlett S K, Reik W. Methylation levels of maternal and paternal genomes during preimplantation development. Development, 1991, 113(1): 119-127
17. Monk M, Adams R L, Rinaldi A. Decrease in DNA methylase activity during preimplantation development in the mouse. Development, 1991, 112(1): 189-192
18. Carlson L L, Page A W, Bestor T H. Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. Genes Dev, 1992, 6 (12B): 2536-2541
19. Rougier N, Bourc' his D, Gomes D M, et al. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev, 1998, 12(14): 2108-2113
20. Ohtani-Fujita N, Fujita T, Aoike A, et al. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene, 1993, 8(4): 1063-1067
21. Herman J G, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 1995, 55(20): 4525-4530
22. Issa J P, Baylin S B, Herman J G. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia, 1997, 11(Suppl 1): S7-11
23. Santini V. Kantarjian H.M. Issa J.-P. Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications Annals of Internal Medicine 2001 134 7 573-586 23 Santini V, Kantarjian H M, Issa J P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med, 2001, 134(7): 573-586 (Pubitemid 32245319)
24. Melki J R, Clark S J. DNA methylation changes in leukaemia. Semin Cancer Biol, 2002, 12(5): 347-357
25. Raman R, Narayan G. 5-AZA deoxycytidine-induced inhibition of differentiation of spermatogonia into spermatocytes in the mouse. Mol Reprod Dev, 1995, 42(3): 284-290
26. Martin C C, Laforest L, Akimenko M A, et al. A role for DNA methylation in gastrulation and somite patterning. Dev Biol, 1999, 206(2): 189-205
27. Gattei V, Aldinucci D, Petti M C, et al. In vitro and in vivo effects of 5-AZA-2' -deoxycytidine (Decitabine) on clonogenic cells from acute myeloid leukemia patients. Leukemia, 1993, 7(Suppl 1): 42-44
28. Juttermann R. Li E. Jaenisch R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 11797-11801 28 Juttermann R, Li E, Jaenisch R. Toxicity of 5-aza-2' -deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA, 1994, 91(25): 11797-11801 (Pubitemid 24985095)
29. Jackson-Grusby L, Laird P W, Magge S N, et al. Mutagenicity of 5-aza-2' -deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc Natl Acad Sci USA, 1997, 94(9): 4681-4685
30. Christman J.K. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy Oncogene 2002 21 35 REV. ISS. 3 5483-5495 DOI 10.1038/sj.onc.1205699 30 Christman J K. 5-AZAcytidine and 5-AZA-2' -deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene, 2002, 21 (35): 5483-5495 (Pubitemid 34983483)
31. Wilson V L, Jones P A, Momparler R L. Inhibition of DNA methylation in L1210 leukemic cells by 5-AZA-2'-deoxycytidine as a possible mechanism of chemotherapeutic action. Cancer Res, 1983, 43(8): 3493-3496
32. Leone G, Teofili L, Voso M T, et al. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias. Haematologica, 2002, 87(12): 1324-1341
33. Lemaire M, Momparler L F, Bernstein M L, et al. Enhancement of antineoplastic action of 5-AZA-2' -deoxycytidine by zebularine on L1210 leukemia. Anticancer Drugs, 2005, 16(3): 301-308
34. Jablonka E, Goitein R, Marcus M, et al. DNA hypomethylation causes an increase in DNase-I sensitivity and an advance in the time of replication of the entire inactive X chromosome. Chromosoma, 1985, 93(2): 152-156
35. Huang Y. Friedman S. Inhibition of recA-mediated strand exchange by adducts of azacytosine-containing DNA and the EcoRII methylase Journal of Biological Chemistry 1991 266 26 17424-17429 35 Huang Y C, Friedman S. Inhibition of recA-mediated strand exchange by adducts of azacytosine-containing DNA and the EcoR II methylase. J Biol Chem, 1991, 266(26): 17424-17429 (Pubitemid 21907956)
36. Yamada T, Ohwada S, Saitoh F, et al. Induction of Ley antigen by 5-AZA-2' -deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells. Anticancer Res, 1996, 16(2): 735-740
37. Hsi L C, Xi X, Wu Y, et al. The methyltransferase inhibitor 5-AZA-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther, 2005, 4(11): 1740-1746
38. Branch S, Francis B M, Brownie C F, et al. Teratogenic effects of the demethylating agent 5-AZA-2' -deoxycytidine in the Swiss Webster mouse. Toxicology, 1996, 112(1): 37-43
39. Branch S, Chemoff N, Brownie C, et al. 5-AZA-2'-deoxycytidineinduced dysmorphogenesis in the rat. Teratog Carcinog Mutagen, 1999, 19(5): 329-338
40. Whitten W K. Nutrient requirement for the culture of preimplantation embryos. Adv Biosci, 1971, 6:129-139
41. Chatot C.L. Ziomek C.A. Bavister B.D. Lewis J.L. Torres I. An improved culture medium supports development of random-bred 1-cel mouse embryos in vitro Journal of Reproduction and Fertility 1989 86 2 679-688 41 Chatot C L, Ziomek C A, Bavister B D, et al. An improved culture medium supports development of random-bred 1-cell mouse embryos in vitro. J Reprod Fertil, 1989, 86(2): 679-688 (Pubitemid 19183391)
42. Aoki F. Worrad D.M. Schultz R.M. Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo Developmental Biology 1997 181 2 296-307 DOI 10.1006/dbio.1996.8466 42 Aoki F, Worrad D M, Schultz R M. Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo. Dev Biol, 1997, 181(2): 296-307 (Pubitemid 27089080)
43. Kafri T, Ariel M, Brandeis M, et al. Developmental pattern of genespecific DNA methylation in the mouse embryo and germ line. Genes Dev, 1992, 6(5): 705-714
44. Rosen M.B. Chernoff N. 5-Aza-2′-deoxycytidine-induced cytotoxicity and limb reduction defects in the mouse Teratology 2002 65 4 180-190 DOI 10.1002/tera.10029 44 Rosen M B, Chemoff N. 5-AZA-2'-deoxycytidine-induced cytotoxicity and limb reduction defects in the mouse. Teratology, 2002, 65(4): 180-190 (Pubitemid 34242117)
45. Hamatani T, Carter M G , Sharov A A, et al. Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell, 2004, 6(1): 117-131
46. Jones P.A. Taylor S.M. Cellular differentiation, cytidine analogs and DNA methylation Cell 1980 20 1 85-93 46 Jones P A, Taylor S M. Cellular differentiation, cytidine analogs and DNA methylation. Cell, 1980,20(1): 85-93 (Pubitemid 10117303)
47. Kelly T.L.J. Li E. Trasler J.M. 5-Aza-2′-Deoxycytidine Induces Alterations in Murine Spermatogenesis and Pregnancy Outcome Journal of Andrology 2003 24 6 822-830 47 Kelly T L, Li E, Trasler J M. 5-AZA-2' -deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome. J Androl, 2003,24(6): 822-830 (Pubitemid 37370538)
48. Issa J P, Garcia-Manero G, Giles F J, et al. Phase 1 study of lowdose prolonged exposure schedules of the hypomethytating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies. Blood, 2004, 103(5): 1635-1640
49. Ratnam S, Mertineit C, Ding F, et al. Dynamics of Dnmt1 methyltransferase expression and intracellular localization during oogenesis and preimplantation development. Dev Biol, 2002, 245 (2): 304-314
50. Nieto M, Samper E, Fraga M F, et al. The absence of p53 is critical for the induction of apoptosis by 5-aza-2'-deoxycytidine. Oncogene, 2004, 23(3): 735-743
51. Ghoshal K, Datta J, Majumder S, et al. 5-AZA- deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol, 2005, 25(11): 4727-4741
52. Yamane K, Suzuki H, Ihn H, et al. Cell type-specific regulation of the TGF-beta-responsive alpha2( I ) collagen gene by CpG methylation. J Cell Physiol, 2005, 202(3): 822-830
53. Dceda K, Iyama K, Ishikawa N, et al. Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am J Pathol, 2006, 168(3): 856-865
54. Issa J P, Gharibyan V, Cortes J, et al. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J Clin Oncol, 2005, 23(17): 3948-3956
55. Branch S, Francis B M, Rosen M B, et al. Differentially expressed genes associated with 5-AZA-2' - deoxycytidine- induced hindlimb defects in the Swiss Webster mouse. J Biochem Mol Toxicol, 1998, 12(3): 135-141
56. Branch S. Smoak I.W. The effects of 5-AZA-2′-deoxycytidine (D-AZA) on sonic hedgehog expression in mouse embryonic limb buds Toxic Substance Mechanisms 2000 19 2 125-133 DOI 10.1080/10769180052008904 56 Branch S. The effects of 5-AZA-2'-deoxycytidine (D-AZA) on sonic hedgehog expression in mouse embryonic limb buds. Toxic Subst Mech, 2000,19(2): 125-133 (Pubitemid 32238213)
57. Branch S. Henry-Sam G. Altered hox gene expression and cellular pathogenesis of 5-aza-2′-deoxycytidine-induced murine hindlimb dysmorphogenesis Toxicologic Pathology 2001 29 5 501-506 DOI 10.1080/019262301317226294 57 Branch S, Henry-Sam G. Altered hox gene expression and cellular pathogenesis of 5-AZA-2' -deoxycytidine-induced murine hindlimb dysmorphogenesis. Toxicol Pathol, 2001, 29(5): 501-506 (Pubitemid 33031598)
58. Arai M, Yokosuka O, Hirasawa Y, et al. Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-AZA-2'-deoxycytidine. Cancer, 2006, 106(11): 2514-2525
59. Kaito C. Kai M. Higo T. Takayama E. Fukamachi H. Sekimizu K. Shiokawa K. Activation of the maternally preset program of apoptosis by microinjection of 5-aza-2′-deoxycytidine and 5-methyl-2′-deoxycytidine-5′- triphosphate in Xenopus laevis embryos Development Growth and Differentiation 2001 43 4 383-390 DOI 10.1046/j.1440-169X.2001.00579.x 59 Kaito C, Kai M, Higo T, et al. Activation of the maternally preset program of apoptosis by microinjection of 5-AZA-2' -deoxycytidine and 5-methyl-2' -deoxycytidine-5' -triphosphate in Xenopus laevis embryos. Dev Growth Differ, 2001, 43(4): 383-390 (Pubitemid 32848260)
60. Howell C Y, Bestor T H, Ding F, et al. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell, 2001, 104(6): 829-838